NEW YORK (
St Jude Medical
) hit a new 52-week high Tuesday as it traded at $50.61 compared with its previous 52-Week high of $50.36. St Jude Medical is changing hands at $50 with 215,106 shares traded as of 9:32 a.m. ET. Average volume has been 3.5 million shares over the past 30 days.
St Jude Medical has a market cap of $15.7 billion and is part of the
industry. Shares are up 13.3% year to date as of the close of trading on Monday.
St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The company has a P/E ratio of 17.5, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 15.8.
- Practice your STJ trading strategies and win cash in our stock game.
TheStreet Ratings rates St Jude Medical as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, reasonable valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full
52-week high stocks
or get investment ideas from our